Maijie Translational Medicine Research
Founded Year
2013Stage
Series B | AliveTotal Raised
$77.11MLast Raised
$51.39M | 2 yrs agoAbout Maijie Translational Medicine Research
Maijie Translational Medicine Research, formerly known as QIAGEN (Suzhou) Translational Medicine, is a translational medicine R&D Corporation and pharmaceutical company that provides complete solutions for precision medicine / personalized healthcare through translational science.
Missing: Maijie Translational Medicine Research's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Maijie Translational Medicine Research's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Maijie Translational Medicine Research Frequently Asked Questions (FAQ)
When was Maijie Translational Medicine Research founded?
Maijie Translational Medicine Research was founded in 2013.
Where is Maijie Translational Medicine Research's headquarters?
Maijie Translational Medicine Research's headquarters is located at Room 901, B5, Bio-Nano Park, 218 Xinghu Street, Suzhou.
What is Maijie Translational Medicine Research's latest funding round?
Maijie Translational Medicine Research's latest funding round is Series B.
How much did Maijie Translational Medicine Research raise?
Maijie Translational Medicine Research raised a total of $77.11M.
Who are the investors of Maijie Translational Medicine Research?
Investors of Maijie Translational Medicine Research include Anjie Investment, Quan Capital, Qiming Venture Partners, Qingsong Capital, Broad Resources Investment Management and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.